‘An AlphaFold 4’ – scientists marvel at DeepMind drug spin-off’s exclusive new AI
Isomorphic Labs unveiled IsoDDE, a proprietary AI engine that claims superior protein–drug and antibody interaction predictions versus open models like Boltz-2, while providing few technical details.
Why it mattersIsomorphic Labs' IsoDDE outperforming Boltz-2 on binding affinity means pharma must prioritize internal AI and proprietary data.